Short-course ceftriaxone reduces hospital stay and adverse events in children with pneumoniaShorter antibiotic courses may help children with pneumonia stay home

Pakistan journal of pharmaceutical sciences Published September 4, 2026 Study authors: Lv Mei, Yang Yang, Fang Liyun, Liu Lei PubMed ↗ DOI ↗ Editorial oversight: Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway

Consider short-course ceftriaxone for mild pneumonia to reduce hospital stay, but use standard-course for severe cases.

This randomized controlled trial evaluated the impact of treatment duration on 200 children aged 1 to 14 years with pneumonia. The study compared a short-course ceftriaxone sodium regimen (5 to 7 days) against a standard-course ceftriaxone sodium regimen (7 to 14 days).

Primary outcomes showed that the overall response rate and symptom relief time were comparable between the short-course and standard-course groups (P>0.05). However, the short-course group demonstrated a statistically significant reduction in hospital stay duration and a lower rate of adverse events (P<0.05).

Conversely, the standard-course group showed a significantly lower recurrence rate (P<0.05) and superior normalization of inflammatory markers by day 5 (P<0.05). Safety data indicated fewer adverse events in the short-course group (P<0.05).

A primary limitation of this study is its single-center design. Clinicians may consider short-course ceftriaxone for mild cases with prompt inflammatory responses, while standard-course therapy may be preferred for severe cases or delayed inflammation to mitigate the risk of relapse.

How this fits prior evidence

How this fits prior evidence: This finding addresses a gap in managing pneumonia in pediatric populations by comparing treatment durations. While prior evidence noted that mNGS achieves an 85.83% pathogen detection rate in children with severe pneumonia compared to 49.97% for conventional methods, this study focuses on the clinical management and duration of ceftriaxone. It does not directly relate to the findings regarding doxycycline for syphilis, topoisomerase II inhibitors for gonorrhoea, iNKT cell activators for stroke-associated pneumonia, or IL-6 as a biomarker for alveolar damage.

When a child is hospitalized with pneumonia, the length of their antibiotic treatment is a big decision for families. Doctors often weigh the benefits of a long course against the risks of side effects and the desire to get the child home as soon as possible. This study looked at whether a shorter course of the antibiotic ceftriaxone could work just as well as the standard longer treatment.

Researchers compared a short course of 5 to 7 days against a standard course of 7 to 14 days in 200 children aged 1 to 14. They found that both groups saw similar overall success in treating the infection and similar times for symptom relief. However, children on the shorter course had shorter hospital stays and experienced fewer adverse events overall.

While the shorter course worked well for some, the results show that the longer course was better at preventing the infection from coming back and lowering inflammatory markers by day 5. Because of these differences, a shorter course may be a good choice for mild cases with a quick response, while the longer course remains better for severe cases or when inflammation takes longer to clear.

What this means for you:

Short-course antibiotics can reduce hospital stays and side effects in children with mild pneumonia.

Common questions

Is a shorter course of antibiotics safe for children with pneumonia?

The study found that a short course of ceftriaxone (5 to 7 days) resulted in fewer adverse events compared to the standard 7 to 14 day course. However, the longer course was more effective at preventing the infection from returning and managing inflammation. Talk to your doctor to decide which length is safest based on your child's specific condition.

How long do children usually need antibiotics for pneumonia?

This study looked at two options: a short course of 5 to 7 days and a standard course of 7 to 14 days. While both were effective at treating the infection, the shorter course led to shorter hospital stays, while the longer course was better at preventing a relapse of the illness.

When is a short course of antibiotics best for a child?

A shorter course of ceftriaxone may be suitable for children with mild cases who show a prompt response to treatment. For children with severe cases or those whose inflammation takes longer to clear, the standard longer course is preferred to prevent the infection from coming back.

Study Details

Study typeRct

Sample sizen = 200

EvidenceLevel 2

Follow-up168.0 mo

PublishedSep 2026

PMID42436624

View Original Abstract ↓

BACKGROUND: Pediatric bacterial pneumonia (30-40% of cases) is commonly treated with ceftriaxone sodium, but optimal duration (traditional 7-14 days vs. short 5-7 days) remains controversial. OBJECTIVES: To compare therapeutic efficacy, inflammatory marker dynamics and safety of short- vs. standard-course ceftriaxone sodium in pediatric pneumonia. METHODS: This prospective, single-center, single-blind, phase randomized controlled trial randomized 200 children (1-14 years) 1:1 to short-course (5-7 days) or standard-course (7-14 days) ceftriaxone sodium. The primary outcome was overall response rate; secondary outcomes included symptom relief time, hospital stay, recurrence, adverse events, and changes in lung function and inflammatory markers. RESULTS: Symptom relief time and overall efficacy were comparable between groups (P>0.05). Short-course ceftriaxone sodium reduced hospital stay and adverse events (P<0.05), while standard-course lowered recurrence rate and achieved superior inflammatory marker normalization by day 5 (P<0.05). CONCLUSION: Short- and standard-course ceftriaxone sodium have similar overall efficacy. A short-course is suitable for mild cases with a prompt inflammatory response, while a standard-course is preferred for severe cases or delayed inflammation to prevent relapse.

Short-course ceftriaxone reduces hospital stay and adverse events in children with pneumoniaShorter antibiotic courses may help children with pneumonia stay home

How this fits prior evidence

Common questions

Study Details

Candidiasis prevalence of 13.46% and Cryptococcal meningitis of 3.15% among HIV-positive individuals

New data shows prevalence of fungal infections in HIV patients

Clinical research that matters. Delivered to your inbox.

Short-course ceftriaxone reduces hospital stay and adverse events in children with pneumoniaShorter antibiotic courses may help children with pneumonia stay home

How this fits prior evidence

Common questions

More on Pneumonia

Study Details

Candidiasis prevalence of 13.46% and Cryptococcal meningitis of 3.15% among HIV-positive individuals

New data shows prevalence of fungal infections in HIV patients

Clinical research that matters. Delivered to your inbox.

Related in Infectious Disease

From Other Specialties